UK markets open in 14 minutes
NIKKEI 225
38,274.05 -131.61 (-0.34%) HANG SENG
17,763.03 +16.12 (+0.09%) CRUDE OIL
81.05 -0.88 (-1.07%) GOLD FUTURES
2,299.00 -3.90 (-0.17%) DOW
37,815.92 -570.17 (-1.49%) Bitcoin GBP
47,900.90 -2,927.63 (-5.76%)
Clinuvel Pharmaceuticals Limited (CLVLF)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
At close: 12:37PM EDT
Currency in USD
Valuation measures4
| Market cap (intra-day) | 494.76M |
| Enterprise value | 381.00M |
| Trailing P/E | 26.05 |
| Forward P/E | 18.12 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 9.72 |
| Price/book (mrq) | 4.19 |
| Enterprise value/revenue | 4.69 |
| Enterprise value/EBITDA | 7.51 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.74 |
| 52-week change 3 | -25.08% |
| S&P500 52-week change 3 | 23.10% |
| 52-week high 3 | 13.15 |
| 52-week low 3 | 8.57 |
| 50-day moving average 3 | 9.20 |
| 200-day moving average 3 | 10.39 |
Share statistics
| Avg vol (3-month) 3 | 516 |
| Avg vol (10-day) 3 | 1.34k |
| Shares outstanding 5 | 50.1M |
| Implied shares outstanding 6 | 50.67M |
| Float 8 | 39.5M |
| % held by insiders 1 | 20.44% |
| % held by institutions 1 | 8.94% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | 0.03 |
| Forward annual dividend yield 4 | 0.33% |
| Trailing annual dividend rate 3 | 0.05 |
| Trailing annual dividend yield 3 | 0.50% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 8.73% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | 05 Sept 2023 |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Currency in AUD.Fiscal year
| Fiscal year ends | 30 Jun 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 36.88% |
| Operating margin (ttm) | 42.37% |
Management effectiveness
| Return on assets (ttm) | 14.71% |
| Return on equity (ttm) | 18.98% |
Income statement
| Revenue (ttm) | 81.76M |
| Revenue per share (ttm) | 1.65 |
| Quarterly revenue growth (yoy) | 11.70% |
| Gross profit (ttm) | N/A |
| EBITDA | 44.36M |
| Net income avi to common (ttm) | 30.15M |
| Diluted EPS (ttm) | 0.37 |
| Quarterly earnings growth (yoy) | -4.00% |
Balance sheet
| Total cash (mrq) | 174.45M |
| Total cash per share (mrq) | 3.52 |
| Total debt (mrq) | 1.07M |
| Total debt/equity (mrq) | 0.60% |
| Current ratio (mrq) | 6.86 |
| Book value per share (mrq) | 3.61 |
Cash flow statement
| Operating cash flow (ttm) | 42.27M |
| Levered free cash flow (ttm) | 31.29M |
© 2024 Yahoo. All rights reserved.